Alan Prem Kumar

Biography

 Metastatic breast cancer is generally considered to be incurable; therefore, new prognostic markers are urgently needed to identify patients at the highest risk for developing metastases and to enable oncologists to begin tailoring targeted treatments. We recently identified a novel oncogene that functions by its ability to activate key oncogenic pathways in breast cancer metastasis and drug resistance. Current research therefore focuses on better understanding the role of this oncogene which offers great potential for the development of more specifically targeted treatment in the battle against cancer and metastatic disease.

Research Interest

 Health Care Studies